Benjamin Edwards Inc. Takes $725,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Benjamin Edwards Inc. bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 12,815 shares of the company's stock, valued at approximately $725,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI in the third quarter valued at $30,000. Vestor Capital LLC purchased a new position in Tempus AI in the 3rd quarter valued at about $153,000. The Manufacturers Life Insurance Company boosted its stake in shares of Tempus AI by 10.2% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company's stock worth $1,686,000 after purchasing an additional 2,765 shares during the last quarter. Sandia Investment Management LP purchased a new stake in shares of Tempus AI during the second quarter worth about $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in shares of Tempus AI in the third quarter valued at approximately $258,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on TEM shares. Piper Sandler restated a "neutral" rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Loop Capital raised their price target on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research note on Tuesday, October 15th. Bank of America downgraded shares of Tempus AI from a "buy" rating to a "neutral" rating and upped their price objective for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Finally, Stifel Nicolaus cut shares of Tempus AI from a "buy" rating to a "hold" rating and raised their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $54.22.

Tempus AI Stock Performance

Tempus AI stock traded down $2.72 during midday trading on Friday, hitting $50.44. 2,810,520 shares of the stock were exchanged, compared to its average volume of 1,422,286. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company has a 50 day simple moving average of $53.54. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.